Authors

  • Mukhiba Begnaeva
  • Mexroj Toshkulov
  • Feruza Yakubova

DOI:

https://doi.org/10.71337/inlibrary.uz.science-research.63873

Keywords:

Pathophysiology Clinical manifestations Diagnostics Neonatal screening.

Abstract

Congenital heart disease is the most common congenital anomaly, occurring in almost 1% of live births ( 1 ). Among birth defects, congenital heart disease is the leading cause of infant mortality. The most common congenital heart defects diagnosed in infancy are muscular and perimembranous ventricular septal defects, followed by secundum atrial septal defects, with an overall prevalence of 48.4 per 10,000 live births ( 2, 3, 4 ). The most common “blue” congenital heart defect is tetralogy of Fallot, which is twice as common as transposition of the great arteries (4.7 versus 2.3 per 10,000 births). Overall, bicuspid aortic valve is the most common congenital heart defect, with a prevalence of 0.5–2.0%.

background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1039

CARDIOVASCULAR DISORDERS CAUSED BY MALNUTRITION IN CHILDREN

Begnaeva Mukhiba

Assistant of the Department of Clinical Pharmacology, Samarkand State Medical University

Toshkulov Mexroj

Yakubova Feruza

Students of the Department of Clinical Pharmacology, Samarkand State Medical University

https://doi.org/10.5281/zenodo.14757090

Abstract. Congenital heart disease is the most common congenital anomaly, occurring in

almost 1% of live births ( 1 ). Among birth defects, congenital heart disease is the leading cause

of infant mortality. The most common congenital heart defects diagnosed in infancy are muscular

and perimembranous ventricular septal defects, followed by secundum atrial septal defects, with

an overall prevalence of 48.4 per 10,000 live births ( 2, 3, 4 ). The most common “blue” congenital

heart defect is tetralogy of Fallot, which is twice as common as transposition of the great arteries

(4.7 versus 2.3 per 10,000 births). Overall, bicuspid aortic valve is the most common congenital

heart defect, with a prevalence of 0.5–2.0%.

Keywords: Pathophysiology, Clinical manifestations, Diagnostics, Neonatal screening.

СЕРДЕЧНО-СОСУДИСТЫЕ ЗАБОЛЕВАНИЯ, ВЫЗВАННЫЕ НЕДОЕДАНИЕМ У

ДЕТЕЙ

Аннотация. Врожденный порок сердца является наиболее распространенной

врожденной аномалией, встречающейся почти у 1% живорожденных (1). Среди

врожденных пороков врожденный порок сердца является основной причиной детской

смертности.

Наиболее

распространенными

врожденными

пороками

сердца,

диагностируемыми в младенчестве, являются мышечные и перимембранозные дефекты

межжелудочковой перегородки, за которыми следуют вторичные дефекты

межпредсердной перегородки, с общей распространенностью 48,4 на 10 000

живорожденных (2, 3, 4). Наиболее распространенным «синим» врожденным пороком

сердца является тетрада Фалло, которая встречается в два раза чаще, чем транспозиция

магистральных артерий (4,7 против 2,3 на 10 000 родов). В целом, двустворчатый

аортальный клапан является наиболее распространенным врожденным пороком сердца с

распространенностью 0,5–2,0%.

Ключевые слова: Патофизиология, Клинические проявления, Диагностика,

Неонатальный скрининг.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1040

Introduction

Common environmental factors include maternal disease (e.g., diabetes mellitus, rubella,

systemic lupus erythematosus) or maternal use of teratogenic agents (e.g., lithium, isotretinoin,

anticonvulsants). Maternal age is a known risk factor for certain genetic disorders, particularly

Down syndrome, in which the fetus may have heart defects. It is not clear whether maternal age is

an independent risk factor for congenital heart defects. Paternal age may also be a risk factor ( 1 ).

Some chromosomal abnormalities (aneuploidies), such as trisomy 21 (Down syndrome),

trisomy 18 (Trysomy 13), and monosomy X (Turner syndrome), are strongly associated with

congenital heart disease. However, some of these abnormalities account for only 5-6% of patients

with congenital heart disease. Many other conditions involve subchromosomal deletions

(microdeletions), subchromosomal duplications, or single gene mutations. These mutations often

cause congenital syndromes that affect multiple organs in addition to the heart. Examples include

DiGeorge syndrome (microdeletion at 22q11.2) and Williams syndrome (sometimes called

Williams-Buren syndrome) (microdeletion at 7p11.23). Single gene defects that cause syndromes

associated with congenital heart disease include mutations in the fibrillin-1 gene (Marfan

syndrome), TXB5 (Holt-Oram syndrome), and PTPN11 (Noonan syndrome). Defects in a single

gene can also cause isolated (i.e., nonsyndromic) congenital heart defects. In approximately 72%

of patients with congenital heart disease, no genetic etiology is identified ( 2 , 3 , 4 ). The risk of

recurrence of congenital heart disease in a family depends on the cause of the disease. The risk for

new mutations is insignificant, ranging from 2% to 5% for nonsyndromic multifactorial congenital

heart disease and 50% if the cause is an autosomal dominant mutation. Family screening for

bicuspid aortic valve in an individual requires screening in a family with a prevalence of 9% ( 5 ).

Identification of genetic factors is important because most patients with congenital heart disease

survive to adulthood and potentially start a family.

Normal fetal circulation

The fetal circulation is characterized by:

The passage of blood around the non-ventilated lung from right to left through the patent

ductus arteriosus (connecting the pulmonary artery to the aorta) and the foramen ovale (connecting

the right and left atria). Shunting is supported by the high resistance of the pulmonary arterioles

and the low resistance to blood flow in the systemic circulation (including the placenta).

Approximately 90–95% of the right ventricular output bypasses the lungs and enters the systemic

circulation directly. The ductus arteriosus of the fetus is maintained open by the low systemic fetal


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1041

PaO2 (approximately 25 mm Hg) and locally produced prostaglandins. The foramen ovale is

maintained open by pressure differences in the atria: the pressure in the left atrium is relatively

low because of the small amount of blood returning from the lungs, and the pressure in the right

atrium is relatively high because of the large volume of blood returning from the placenta.

Normal fetal circulation

In the fetus, the blood entering the right side of the heart is already saturated with oxygen

through the placenta. Since the lungs are not ventilated, only a small amount of blood passes

through the pulmonary artery. Most of the blood from the right side of the heart bypasses the lungs.

a.

Oval mirror

b.

Ductus arteriosus

c.

Typically, these two structures close naturally soon after birth.

d.

Normal fetal circulation

e.

Changes in the perinatal period

f.

Extensive changes in this system occur after the first breath, resulting in

g.

Increased pulmonary blood flow

h.

Functional closure of the foramen ovale

Pulmonary arteriolar resistance decreases dramatically due to vasodilation caused by lung

expansion, increased PaO2, and decreased PaCO2. Elastic forces of the ribs and chest wall

decrease pulmonary interstitial pressure, further increasing blood flow through the pulmonary

capillaries. Increased venous return from the lungs increases left atrial pressure, which reduces the

pressure difference between the left and right atria; this effect contributes to functional closure of

the foramen ovale. Once pulmonary blood flow is established, venous return from the lungs

increases, and left atrial pressure increases. Inhaled air increases PaO2, which causes the umbilical

arteries to constrict. Placental blood flow is reduced or stopped, reducing arterial return to the right

atrium. Thus, the pressure in the right atrium decreases, while the pressure in the left atrium

increases. As a result, these 2 embryonic components of the interatrial septum (septum primum

and septum secundum) are simultaneously compressed, which prevents flow through the foramen

ovale. In most individuals, these 2 membranes eventually fuse, and the foramen ovale disappears.

However, in 25% of adults, the foramen ovale may remain patent with minimal or no

residual shunting ( 1 ). Shortly after birth, systemic resistance becomes higher than pulmonary

resistance, completely changing from the fetal state. Thus, the direction of blood flow through the

ductus arteriosus is reversed, forming a left-to-right shunt of blood (the so-called transitional


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1042

circulation). This state lasts from birth (when blood flow in the lungs increases and functional

closure of the foramen ovale occurs) until about 24-72 hours later, when the ductus arteriosus

narrows. The blood entering the ductus from the aorta and its veins has a high PO2, which,

together with changes in prostaglandin metabolism, leads to narrowing and closure of the ductus

arteriosus. As soon as the ductus closes, the adult type of circulation is formed. At the same time,

the two ventricles are constantly contracting, and there is no significant connection between the

pulmonary and systemic circulation.

If there is stress immediately after birth, the newborn may revert to fetal circulation.

Asphyxia with hypoxia and hypercapnia leads to constriction of the pulmonary arterioles and

dilation of the ductus arteriosus, which leads to the reversal of the processes described above and

the restoration of right-to-left shunting of blood through the newly opened ductus arteriosus and/or

the foramen magnum. Consequently, the newborn is severely hypoxemic, a condition called

persistent pulmonary hypertension or persistent fetal circulation (although umbilical circulation is

not present). The goal of treatment is to eliminate the conditions that cause pulmonary

vasoconstriction.

Pathophysiology of congenital heart defects

Congenital heart defects are classified as follows (see table: Classification of Congenital

Heart Defects):

1.

Cyanotic

2.

Asiatic (left-to-right shunts or obstructive lesions)

The physiological consequences of congenital heart anomalies are very diverse, ranging

from a heart murmur or pulse discrepancy in an asymptomatic child to severe cyanosis, heart

failure, or vascular insufficiency.

Cyanotic heart anomalies

Various amounts of deoxygenated venous blood are shunted to the left side of the heart

(right to left), which reduces systemic arterial oxygen saturation.

Cyanosis develops if > 5 g/dL (>50 g/L) of deoxygenated hemoglobin is present.

Complications of chronic cyanosis include polycythemia, thromboembolism (including

stroke), bleeding disorders, brain abscess, and hyperuricemia. Hypercyanotic seizures may occur

in infants with untreated tetralogy of Fallot or other complex congenital malformations involving

dynamic stenosis of the subpulmonary valve and ventricular defects.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1043

Depending on the abnormality, pulmonary blood flow may be reduced, normal, or

increased (often resulting in heart failure in addition to cyanosis), resulting in varying degrees of

cyanosis. Heart murmurs with variable sound are nonspecific.

Left to right shunts

Oxygenated blood from the left side of the heart (left atrium or left ventricle), or the aorta,

is sent to the right side of the heart (right atrium or right ventricle), or the pulmonary artery, through

a hole or junction between the 2 parts.

Immediately after birth, pulmonary vascular resistance is high, and flow through this

connection may be minimal or bidirectional. During the first 24 to 48 hours of life, pulmonary

vascular resistance gradually decreases, with increased left-to-right blood flow. The additional

blood flow to the right side increases pulmonary blood flow and pulmonary artery pressure to

varying degrees. The greater the increase, the more severe the symptoms; a small right-to-left shunt

usually causes no symptoms or signs.

High-pressure anastomoses (in the ventricles or large arteries) become apparent within

days to weeks; low-pressure shunts (atrial septal defects) become apparent much later. If left

untreated, increased pulmonary blood flow and pulmonary artery pressure can lead to pulmonary

vascular disease and ultimately Eisenmenger syndrome. Large left-to-right shunts (eg, large

ventricular septal defect [VSD], patent ductus arteriosus [PDA]) cause excessive pulmonary blood

flow and left ventricular volume overload, which can lead to the development of signs of heart

failure and often results in heart failure in infancy. Large left-to-right shunts also reduce lung

compliance and increase airway resistance. Together, these factors increase the likelihood of

infants being hospitalized with respiratory syncytial virus or other upper or lower respiratory tract

infections.

Obstructive lesions

Blood flow is obstructed, causing a pressure gradient to develop across the obstruction.

Ventricular hypertrophy and heart failure may develop as a result of excessive pressure

load proximal to the obstruction. The most obvious manifestation is a heart murmur caused by

turbulent flow through the obstruction (stenosis). For example, congenital aortic stenosis, which

accounts for 3–6% of congenital heart defects, and congenital pulmonary stenosis, which accounts

for 8–12% ( 1 , 2 ).

Heart failure


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1044

Some congenital heart defects (e.g., bicuspid aortic valve, mild aortic stenosis) do not

significantly alter hemodynamics. Other defects cause pressure or volume overload, sometimes

leading to heart failure. Heart failure develops when cardiac output is insufficient to meet the

metabolic needs of the div or when the heart is unable to adequately maintain venous return, with

pulmonary edema (in left ventricular failure), edema primarily in the tissues and organs of the

abdominal cavity (in right ventricular failure), or both. There are many causes of heart failure in

infants and children other than congenital heart defects (see table: " Common Causes of Heart

Failure in Children "). Abstract: Congenital heart disease is the most common congenital anomaly,

occurring in almost 1% of live births ( 1 ). Among birth defects, congenital heart disease is the

leading cause of infant mortality.

The most common congenital heart defects diagnosed in infancy are muscular and

perimembranous ventricular septal defects, followed by secundum atrial septal defects, with an

overall prevalence of 48.4 per 10,000 live births ( 2, 3, 4 ). The most common “blue” congenital

heart defect is tetralogy of Fallot, which is twice as common as transposition of the great arteries

(4.7 versus 2.3 per 10,000 births). Overall, bicuspid aortic valve is the most common congenital

heart defect, with a prevalence of 0.5–2.0%.

Common causes of heart failure in children

Congenital heart defect related to the ductus arteriosus

Patent ductus arteriosus is the normal connection between the pulmonary artery and the

aorta; it is essential for proper fetal circulation. At birth, an increase in PaO2 and a decrease in

prostaglandin concentrations lead to closure of the ductus arteriosus, which usually begins in the

first 10-15 hours of life. Some congenital heart defects depend on the ductus arteriosus to remain

open to maintain systemic blood flow (e.g., hypoplastic left heart syndrome, critical aortic stenosis,

coarctation of the aorta) or pulmonary blood flow (cyanotic lesions such as pulmonary atresia or

severe tetralogy of Fallot). Thus, with these defects, it is essential to maintain the ductus arteriosus

in a patent state until definitive repair (usually by surgery) is achieved using intravenous

administration of exogenous prostaglandins. Other abnormalities on physical examination include

circulatory shock, circulatory collapse, abnormal 2nd heart sound (single or sharply divided S2),

systolic click, galloping rhythm, or an abnormally slow, fast, or irregular rhythm.

Noises

Left-to-right shunts and obstructive lesions often produce a systolic murmur. The systolic

murmur and chest wall vibration are close to their origin on the div surface, making this location


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1045

diagnostically useful. Increased flow through the pulmonary or aortic valve produces a

mesosystolic murmur (systolic ejection). Regurgitant flow through the ventricular valve or through

a ventricular septal defect produces a holosystolic (pansystolic) murmur that, as its intensity

increases, obscures the first heart sound (S1). Patent ductus arteriosus usually produces a

continuous murmur that is not interrupted by S2 as blood flows through the ductus during systole

and diastole. This murmur is 2-tone and has a sharper sound during systole (induced by high

pressure) than during diastole.

Cyanosis

Thickening of the terminal phalanges of the fingers

Central cyanosis is characterized by a bluish tinge to the lips and tongue and/or nail beds;

it occurs when the deoxygenated hemoglobin level is increased (at least 5 g/dL [50 g/dL]) and

indicates low oxygen levels (usually oxygen saturation <85%). Perioral cyanosis and acrocyanosis

(bluish discoloration of the hands and feet), without cyanosis of the lips or nail beds, are caused

by peripheral vasoconstriction rather than hypoxemia and are common, normal findings in

newborns. Older children with prolonged cyanosis often develop the drumstick sign.

Heart failure

1.

Signs and symptoms of heart failure in infants include:

2.

Tachycardia

3.

Tachypnea

4.

Shortness of breath during feeding

5.

Diaphoresis, especially while eating

6.

Anxiety, nervousness

7.

Hepatomegaly

8.

Poor weight gain

Feeding dyspnea causes malnutrition and poor growth, which may be exacerbated by the

increased metabolic demands associated with HF and frequent respiratory tract infections. Unlike

adults and older children, most infants do not have dilated jugular veins and associated edema, but

they sometimes have significant periorbital edema.

REFERENCES

1.

Мурадова Р. Р., Хайдаров М. М., Омонов Э. М. ОПТИМИЗАЦИЯ ТЕРАПИИ
БОЛЬНЫХ С ОТКРЫТОУГОЛЬНОЙ ГЛАУКОМОЙ С УЧЕТОМ ПАРАМЕТРОВ


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1046

СОСТОЯНИЯ МИКРОЦИРКУЛЯТОРНОГО РУСЛА ЦЕНТРАЛЬНОЙ ЗОНЫ
СЕТЧАТКИ //Вопросы науки и образования. – 2021. – №. 10 (135). – С. 66-69.

2.

Хайитов У., Ахмедов Ю., Бегнаева М. Клинико-ренtгенологическая картина
септической пневмонии у детей //Журнал гепато-гастроэнтерологических
исследований. – 2021. – Т. 2. – №. 3.2. – С. 35-36.

3.

Меликова Д. У., Бегнаева М. У. CLINICAL FEATURES OF CHRONIC
PYELONEPHRITIS IN CHILDREN //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И
УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2022. – Т. 3. – №. 2.

4.

Мурадова Р. Р., Хайдаров М. М., Бегнаева М. У. СОВРЕМЕННЫЕ КЛИНИКО-
ФАРМАКОЛОГИЧЕСКИЕ АСПЕКТЫ ПРИМЕНЕНИЯ НЕФРОТОКСИЧНЫХ
АНТИБИОТИКОВ //Достижения науки и образования. – 2021. – №. 3. – С. 98-100.

5.

Нуралиева Р. М., Мурадова Р. Р. ЭФФЕКТИВНОСТЬ ПРЕПАРАТА ГАЛСТЕНА ДЛЯ
ЛЕЧЕНИЯ ДЕТЕЙ С ЗАБОЛЕВАНИЯМИ ПЕЧЕНИ //Academic research in educational
sciences. – 2021. – Т. 2. – №. 11. – С. 1435-1439.

6.

Andryev S. et al. Experience with the use of memantine in the treatment of cognitive
disorders //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 282-288.

7.

Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood lymphocytes
with a risk of developing antipsychotic extrapyramidal diseases //Science and innovation. –
2023. – Т. 2. – №. D11. – С. 29-35.

8.

Asanova R. et al. Features of the treatment of patients with mental disorders and
cardiovascular pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 545-550.

9.

Begbudiyev M. et al. Integration of psychiatric care into primary care //Science and
innovation. – 2023. – Т. 2. – №. D12. – С. 551-557.

10.

Bo’Riyev B. et al. Features of clinical and psychopathological examination of young
children //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 558-563.

11.

Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-
functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11.
– С. 36-41.

12.

Ivanovich U. A. et al. Efficacy and tolerance of pharmacotherapy with antidepressants in
non-psychotic depressions in combination with chronic brain ischemia //Science and
Innovation. – 2023. – Т. 2. – №. 12. – С. 409-414.

13.

Nikolaevich R. A. et al. Comparative effectiveness of treatment of somatoform diseases in
psychotherapeutic practice //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 898-903.

14.

Novikov A. et al. Alcohol dependence and manifestation of autoagressive behavior in
patients of different types //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 413-419.

15.

Pachulia Y. et al. Assessment of the effect of psychopathic disorders on the dynamics of
withdrawal syndrome in synthetic cannabinoid addiction //Science and innovation. – 2023.
– Т. 2. – №. D12. – С. 240-244.

16.

Pachulia Y. et al. Neurobiological indicators of clinical status and prognosis of therapeutic
response in patients with paroxysmal schizophrenia //Science and innovation. – 2023. – Т.
2. – №. D12. – С. 385-391.


background image

ISSN:

2181-3906

2025

International scientific journal

«MODERN

SCIENCE

АND RESEARCH»

VOLUME 4 / ISSUE 1 / UIF:8.2 / MODERNSCIENCE.UZ

1047

17.

Pogosov A. et al. Multidisciplinary approach to the rehabilitation of patients with somatized
personality development //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 245-251.

18.

Pogosov A. et al. Rational choice of pharmacotherapy for senile dementia //Science and
innovation. – 2023. – Т. 2. – №. D12. – С. 230-235.

19.

Pogosov S. et al. Gnostic disorders and their compensation in neuropsychological syndrome
of vascular cognitive disorders in old age //Science and innovation. – 2023. – Т. 2. – №. D12.
– С. 258-264.

20.

Pogosov S. et al. Prevention of adolescent drug abuse and prevention of yatrogenia during
prophylaxis //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 392-397.

21.

Pogosov S. et al. Psychogenetic properties of drug patients as risk factors for the formation
of addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 186-191.

22.

Prostyakova N. et al. Changes in the postpsychotic period after acute polymorphic disorder
//Science and innovation. – 2023. – Т. 2. – №. D12. – С. 356-360.

23.

Prostyakova N. et al. Issues of professional ethics in the treatment and management of
patients with late dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 158-
165.

24.

Prostyakova N. et al. Sadness and loss reactions as a risk of forming a relationship together
//Science and innovation. – 2023. – Т. 2. – №. D12. – С. 252-257.

25.

Prostyakova N. et al. Strategy for early diagnosis with cardiovascular diseaseisomatized
mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 166-172.

26.

Rotanov A. et al. Comparative effectiveness of treatment of somatoform diseases in
psychotherapeutic practice //Science and innovation.

– 2023. – Т. 2. – №. D12. – С. 267-272.

27.

Rotanov A. et al. Diagnosis of depressive and suicidal spectrum disorders in students of a
secondary special education institution //Science and innovation. – 2023. – Т. 2. – №. D11.
– С. 309-315.

28.

Rotanov A. et al. Elderly epilepsy: neurophysiological aspects of non-psychotic mental
disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 192-197.

29.

Rotanov A. et al. Social, socio-cultural and behavioral risk factors for the spread of hiv
infection //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 49-55.

30.

Rotanov A. et al. Suicide and epidemiology and risk factors in oncological diseases //Science
and innovation. – 2023. – Т. 2. – №. D12. – С. 398-403.

31.

Sedenkov V. et al. Clinical and socio-demographic characteristics of elderly patients with
suicide attempts //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 273-277.

32.

Sedenkov V. et al. Modern methods of diagnosing depressive disorders in neurotic and
affective disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 361-366.

33.

Мурадова Р. Р., Хайдаров М. М. КЛИНИКО-ФАРМАКОЛОГИЧЕСКИЕ АСПЕКТЫ
ПРИМЕНЕНИЯ ГОРМОНАЛЬНЫХ ПРЕПАРАТОВ В ОФТАЛЬМОЛОГИИ
//Достижения науки и образования. – 2021. – №. 3 (75). – С. 100-102.

34.

Kurbonalievich A. S. et al. Experience of the Combination of Tiflox and Immunomax in the
Treatment of Trichomoniasis Combined with a Bacterial Process //Annals of the Romanian
Society for Cell Biology. – 2021. – С. 2376-2380.

References

Мурадова Р. Р., Хайдаров М. М., Омонов Э. М. ОПТИМИЗАЦИЯ ТЕРАПИИ БОЛЬНЫХ С ОТКРЫТОУГОЛЬНОЙ ГЛАУКОМОЙ С УЧЕТОМ ПАРАМЕТРОВ СОСТОЯНИЯ МИКРОЦИРКУЛЯТОРНОГО РУСЛА ЦЕНТРАЛЬНОЙ ЗОНЫ СЕТЧАТКИ //Вопросы науки и образования. – 2021. – №. 10 (135). – С. 66-69.

Хайитов У., Ахмедов Ю., Бегнаева М. Клинико-ренtгенологическая картина септической пневмонии у детей //Журнал гепато-гастроэнтерологических исследований. – 2021. – Т. 2. – №. 3.2. – С. 35-36.

Меликова Д. У., Бегнаева М. У. CLINICAL FEATURES OF CHRONIC PYELONEPHRITIS IN CHILDREN //ЖУРНАЛ РЕПРОДУКТИВНОГО ЗДОРОВЬЯ И УРО-НЕФРОЛОГИЧЕСКИХ ИССЛЕДОВАНИЙ. – 2022. – Т. 3. – №. 2.

Мурадова Р. Р., Хайдаров М. М., Бегнаева М. У. СОВРЕМЕННЫЕ КЛИНИКО-ФАРМАКОЛОГИЧЕСКИЕ АСПЕКТЫ ПРИМЕНЕНИЯ НЕФРОТОКСИЧНЫХ АНТИБИОТИКОВ //Достижения науки и образования. – 2021. – №. 3. – С. 98-100.

Нуралиева Р. М., Мурадова Р. Р. ЭФФЕКТИВНОСТЬ ПРЕПАРАТА ГАЛСТЕНА ДЛЯ ЛЕЧЕНИЯ ДЕТЕЙ С ЗАБОЛЕВАНИЯМИ ПЕЧЕНИ //Academic research in educational sciences. – 2021. – Т. 2. – №. 11. – С. 1435-1439.

Andryev S. et al. Experience with the use of memantine in the treatment of cognitive disorders //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 282-288.

Antsiborov S. et al. Association of dopaminergic receptors of peripheral blood lymphocytes with a risk of developing antipsychotic extrapyramidal diseases //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 29-35.

Asanova R. et al. Features of the treatment of patients with mental disorders and cardiovascular pathology //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 545-550.

Begbudiyev M. et al. Integration of psychiatric care into primary care //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 551-557.

Bo’Riyev B. et al. Features of clinical and psychopathological examination of young children //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 558-563.

Borisova Y. et al. Concomitant mental disorders and social functioning of adults with high-functioning autism/asperger syndrome //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 36-41.

Ivanovich U. A. et al. Efficacy and tolerance of pharmacotherapy with antidepressants in non-psychotic depressions in combination with chronic brain ischemia //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 409-414.

Nikolaevich R. A. et al. Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice //Science and Innovation. – 2023. – Т. 2. – №. 12. – С. 898-903.

Novikov A. et al. Alcohol dependence and manifestation of autoagressive behavior in patients of different types //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 413-419.

Pachulia Y. et al. Assessment of the effect of psychopathic disorders on the dynamics of withdrawal syndrome in synthetic cannabinoid addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 240-244.

Pachulia Y. et al. Neurobiological indicators of clinical status and prognosis of therapeutic response in patients with paroxysmal schizophrenia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 385-391.

Pogosov A. et al. Multidisciplinary approach to the rehabilitation of patients with somatized personality development //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 245-251.

Pogosov A. et al. Rational choice of pharmacotherapy for senile dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 230-235.

Pogosov S. et al. Gnostic disorders and their compensation in neuropsychological syndrome of vascular cognitive disorders in old age //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 258-264.

Pogosov S. et al. Prevention of adolescent drug abuse and prevention of yatrogenia during prophylaxis //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 392-397.

Pogosov S. et al. Psychogenetic properties of drug patients as risk factors for the formation of addiction //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 186-191.

Prostyakova N. et al. Changes in the postpsychotic period after acute polymorphic disorder //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 356-360.

Prostyakova N. et al. Issues of professional ethics in the treatment and management of patients with late dementia //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 158-165.

Prostyakova N. et al. Sadness and loss reactions as a risk of forming a relationship together //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 252-257.

Prostyakova N. et al. Strategy for early diagnosis with cardiovascular diseaseisomatized mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 166-172.

Rotanov A. et al. Comparative effectiveness of treatment of somatoform diseases in psychotherapeutic practice //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 267-272.

Rotanov A. et al. Diagnosis of depressive and suicidal spectrum disorders in students of a secondary special education institution //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 309-315.

Rotanov A. et al. Elderly epilepsy: neurophysiological aspects of non-psychotic mental disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 192-197.

Rotanov A. et al. Social, socio-cultural and behavioral risk factors for the spread of hiv infection //Science and innovation. – 2023. – Т. 2. – №. D11. – С. 49-55.

Rotanov A. et al. Suicide and epidemiology and risk factors in oncological diseases //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 398-403.

Sedenkov V. et al. Clinical and socio-demographic characteristics of elderly patients with suicide attempts //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 273-277.

Sedenkov V. et al. Modern methods of diagnosing depressive disorders in neurotic and affective disorders //Science and innovation. – 2023. – Т. 2. – №. D12. – С. 361-366.

Мурадова Р. Р., Хайдаров М. М. КЛИНИКО-ФАРМАКОЛОГИЧЕСКИЕ АСПЕКТЫ ПРИМЕНЕНИЯ ГОРМОНАЛЬНЫХ ПРЕПАРАТОВ В ОФТАЛЬМОЛОГИИ //Достижения науки и образования. – 2021. – №. 3 (75). – С. 100-102.

Kurbonalievich A. S. et al. Experience of the Combination of Tiflox and Immunomax in the Treatment of Trichomoniasis Combined with a Bacterial Process //Annals of the Romanian Society for Cell Biology. – 2021. – С. 2376-2380.